Cargando…
A flexible mixed‐data model applied to claims data for post‐market surveillance of prescription drug safety behavior
We develop a new modeling framework for jointly modeling first prescription times and the presence of risk‐mitigating behavior for prescription drugs using real‐world data. We are interested in active surveillance of clinical quality improvement programs, especially for drugs which enter the market...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546139/ https://www.ncbi.nlm.nih.gov/pubmed/35373459 http://dx.doi.org/10.1002/pst.2213 |